NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 201 filers reported holding NEVRO CORP in Q1 2022. The put-call ratio across all filers is 1.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $17,511,000 | -30.0% | 216,000 | -44.0% | 0.37% | -59.2% |
| Q2 2019 | $25,024,000 | -30.9% | 386,000 | -33.4% | 0.90% | -35.3% |
| Q1 2019 | $36,222,000 | +1.9% | 579,463 | -36.6% | 1.39% | -2.4% |
| Q4 2018 | $35,556,000 | +18.8% | 914,273 | +74.1% | 1.42% | +32.7% |
| Q3 2018 | $29,927,000 | +6.8% | 525,040 | +39.5% | 1.07% | -28.2% |
| Q2 2017 | $28,009,000 | -25.8% | 376,308 | -6.6% | 1.49% | +2.6% |
| Q1 2017 | $37,761,000 | -30.8% | 402,998 | -46.4% | 1.46% | -35.2% |
| Q4 2016 | $54,589,000 | -2.5% | 751,298 | +40.1% | 2.25% | -13.7% |
| Q3 2016 | $55,990,000 | +38.3% | 536,355 | -48.8% | 2.60% | +79.0% |
| Q4 2014 | $40,491,000 | – | 1,047,093 | – | 1.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tiger Eye Capital LLC | 239,122 | $41,392,000 | 8.25% |
| Integral Health Asset Management, LLC | 88,000 | $15,233,000 | 4.53% |
| Iron Triangle Partners LP | 168,761 | $29,213,000 | 3.79% |
| Eos Focused Equity Management, L.P. | 14,002 | $2,424,000 | 2.37% |
| PFM Health Sciences, LP | 311,940 | $53,997,000 | 1.90% |
| Perceptive Advisors | 977,565 | $169,217,000 | 1.82% |
| Rock Springs Capital Management LP | 395,000 | $68,375,000 | 1.45% |
| Lisanti Capital Growth, LLC | 54,302 | $9,400,000 | 1.30% |
| HealthCor Management, L.P. | 156,046 | $27,012,000 | 1.04% |
| FRED ALGER MANAGEMENT, LLC | 2,136,612 | $369,848,000 | 0.96% |